Use of a compound antagonist of ESM-1 protein for producing a medicine for treating cancer
US7306797B2 · kind B2 · utility
0Cited by
2References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 8, 2001 |
| Grant date | Dec 11, 2007 |
| Priority date | — |
| Expiry date | Feb 26, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of an antagonist compound of protein ESM-1 for the production of a drug for the treatment of a cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.